All IndicationsOncology
🎗️
Leukemia, Acute Myeloid (AML)
1
Companies
1
Drug Programs
1
Phase 3
0
Upcoming PDUFAs
Competitors
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| 4503.T Astellas Pharma Inc. | LoDAC (Low Dose Cytarabine) | Phase 3 | — | — | — |
Development Stage Distribution
Phase 3
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.
